Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Migraine

Free Subscription 16.02.2026 2 Cephalalgia 4 Headache 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Cephalalgia

1. DE BOER I, Kopruszinski CM
   2025 Highlights in sex and gender differences in migraine.
   Cephalalgia. 2026;46:3331024261417385.
   PubMed        
   
   
2. IANNONE LF, Piella EM, Montisano DA, Fasano C, et al
   Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).
   Cephalalgia. 2026;46:3331024251414659.
   PubMed         Abstract available
   
   

   
   Headache

3. 
   Correction to "Migraine and air pollution: A systematic review".
   Headache. 2026 Feb 12. doi: 10.1111/head.70053.
   PubMed        
   
   
4. GRAVES KS, To J, Paige H, Kennedy AG, et al
   Evaluating dual calcitonin gene-related peptide antagonists for chronic migraine prevention.
   Headache. 2026 Feb 12. doi: 10.1111/head.70057.
   PubMed         Abstract available
   
   
5. CHARLESTON L 4TH, Armand CE, Monteith TS, O'Brien HL, et al
   Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo-controlled clinical trials.
   Headache. 2026 Feb 6. doi: 10.1111/head.70034.
   PubMed         Abstract available
   
   
6. TOURLAS K, Ilangovan S, White C, Irwin SL, et al
   Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents.
   Headache. 2026 Feb 6. doi: 10.1111/head.70033.
   PubMed         Abstract available
   
   

   
   PLoS One

7. HUANG Y, Liu D, Zhang H, Xu X, et al
   Trends and age-period-cohort analysis of migraine incidence in China from 1990 to 2021.
   PLoS One. 2026;21:e0338930.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum